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Synthesis and characterization of bivalent peptide ligands 
targeted to G-protein-coupled receptors 
Michael D Carrithersl and Michael R Lerner2T3+ 
Background: Through the effects of avidity, multivalency can increase the 
apparent affinity of a ligand for its binding site. Low molecular weight, high 
affinity, multivalent ligands theoretically could be used to deliver a variety of 
agents to specific cell subtypes. In order to target specific G-protein-coupled 
receptors, a series of monospecific peptide dimers were synthesized that are 
designed to bind to two adjacent receptor sites. 
Results: Three dimers, consisting of a ligand region, a short, flexible, uncharged 
spacer, a longer, polylysine spacer and a single cysteine residue to permit 
dimerization, and the corresponding monomers were synthesized by solid-phase 
peptide synthesis. The ligand domain was either a-melanocyte stimulating 
hormone (wMSH), an a-MSH receptor antagonist ((w-MSH-ANT), or bombesin. 
These ligands were characterized in a functional melanocyte dispersion assay. In 
wild-type melanophores, the CX-MSH dimer stimulated dispersion with an EC,, 
approximately seven-fold lower than that of the corresponding monomer. 
Similarly, in cells transfected with bombesin receptor cDNA, the bombesin dimer 
was approximately five-fold more potent than the monomer. The a-MSH-ANT 
monomer specifically inhibited cl-MSH-mediated dispersion with no significant 
agonist activity, but the dimer acted predominantly as an agonist. 
Conclusions: Peptide dimers can be synthesized easily and have enhanced 
functional activity; monospecific dimers have greater avidity and bispecific 
dimers are likely to have greater selectivity. They may therefore have practical 
potential as specific cell-targeting agents. 
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Introduction 
The high affinity of immunoglobulins for their binding 
sites is at least partially attributable to their multivalency. 
Based on the entropic effects of avidity, multivalency can 
theoretically increase apparent binding affinity by several 
orders of magnitude [l]. Although the observed affinity 
gain is usually more modest, multivalent molecules have 
potentially powerful applications in clinical pharmacology. 
For example, synthetic bivalent ligands can be used to 
target toxins, drugs and, potentially, plasmid DNA to 
specific cell subtypes. 
Thermodynamically, the binding of a multivalent anti- 
body to adjacent epitopes on the cell surface is similar to 
the chelate effect [2,3]. Although this effect was 
described originally to explain the enhanced stability of 
chelate rings, it is also relevant in rate accelerations of 
enzymic reactions and in base-pair formation by 
polynucleotides [4,5]. The common feature of these 
reactions is that following the initial reaction (e.g., 
binding of one antibody ‘arm’ to its antigen), each 
succeeding reaction (e.g., binding of the second antibody 
‘arm’ to an adjacent epitope) is more favorable because 
the entropy loss is decreased. 
Specific examples of bivalent molecules include small 
bivalent antibodies composed of either antibody 
fragments (Fab) or single chain antibodies (F,) [6-B]. In 
addition, numerous other multivalent molecules have 
been designed, including bivalent carbohydrates and a 
variety of synthetic drug delivery systems [9,10]. 
Bivalent peptides, such as receptor-adhesive modular 
proteins (RAMPS), represent an alternative approach to 
cell targeting [11,12]. These large synthetic peptides, 
which contain two ligand sites separated by a spacer 
region and a dimerization domain, are designed to bind to 
two membrane receptors simultaneously. In the original 
design, the dimerization domain consisted of a two- 
stranded parallel o-helical coiled coil, and the ligand 
region was composed of two identical integrin receptor 
binding peptidts. The two ligand domains were separated 
by at least 50 A, but the authors were unable to detect 
increased affinity of their dimeric constructs. These 
results suggested that these dimers could not bind to two 
receptors at the same time. 
We here propose a simplified approach for the synthesis 
of peptide dimers. The design consists of monomeric 
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ligands with a ligand domain, a short, uncharged spacer 
region, a longer, charged polylysine region and a sulf- 
hydryl dimerization domain. The monomers can be syn- 
thesized rapidly by solid-phase peptide synthesis and 
dimerized by oxidation. This design provides both 
proper spacing between the ligands and appropriate 
flexibility. In addition, the polylysine region permits the 
conjugation of small molecular weight drugs to the dimer 
and could also allow its incorporation into a synthetic 
gene-therapy vector [ 131. 
We report the design and synthesis of three monospecific 
peptide dimers to target two specific G-protein-coupled 
receptors. Prior work in another laboratory demonstrated 
that antibody-mediated dimerization of an agonist of the 
gonadotropin-releasing hormone receptor resulted in a 
modest increase in functional activity and that antagonist 
dimerization caused conversion of the ligand to an agonist 
[14,1.5]. Here we have used ligand-binding domains consis- 
ting of ol-melanocyte stimulating hormone (o-MSH), an 
a-MSH receptor antagonist (IX-MSH-ANT) [16], or the 
neuropeptide bombesin. The dimeric and monomeric 
forms of these constructs were characterized functionally in 
a melanocyte dispersion assay [ 17-201. 
Results 
Peptide design and synthesis 
Our goal was to design a dimer that had the potential to 
bind to two receptor sites simultaneously. We reasoned 
that the spacer region needed to be long enough to span 
two receptors but flexible enough to permit binding to the 
second site. Prior work in other laboratories suggested that 
the minimal di:tance between two G-protein-coupled 
receptors is 40 A [Zl]. In addition, structural studies of 
immunoglobulins have demonstrated that the distance 
between antigen binding sites is 100-150 A [l]. The 
spacer region, therefore, needed to consist of residues that 
could assume an extended secondary structure. Initial 
attempts to use a polyglycine or a polyproline spacer 
proved unsuccessful because of solubility and flexibility 
limitations, respectively. 
To achieve the goals of length, flexibility, solubility and 
maintenance of specific ligand binding, the final design 
consisted of a polylysine backbone coupled to the ligand 
region by an uncharged spacer. Representative constructs 
are shown in Figure 1. For the a-MSH and CX-MSH-ANT 
dimers, the amino-terminal region consisted of the ligand- 
binding domain. This was followed by a short, uncharged 
region consisting of three glycine residues and an amino- 
hexanoic acid spacer, a longer, charged spacer region of 20 
lysine residues, a cysteine residue (absent in the 
monomeric peptides) and, finally, a P-alanine residue at 
the carboxyl terminus. The bombesin ligand was 
synthesized in the opposite direction with the ligand- 
binding domain at the carboxyl terminus because, unlike 
Figure 1 
(a) SYSMEHFRWGKPV-GGG-eAhx-Kt2&f3AIa 
I 
SYSMEHFRWGKPV-GGG-eAhx-K~20)-C-f3AIa 
tb) SYSMEHFRWGKPV-GGG-EAhx-Kl,,)-PAla 
(cl MPdFRdWFKPV-GGG-eAhx-K~,o)-C-PAla 
I 
MPdFRdWFKPV-GGG-eAhx-K~20)-C-f3Ala 
00 MPdFRdWFKPV-GGG-eAhx-K~20#Ala 
(e) C-K t201-eAhx-GGG-QQRLGNQWAVGHLM 
I 
C-Kt20j-eAhx-GGG-QQRLGNQWAVGHLM 
0 Kt2pAhx-GGG-QQRLGNQWAVGHLM 
Three pairs of monomers and dimers were synthesized for the present 
study. For the (a) a-MSH dimer, (b) wMSH monomer, (c) a-MSH-ANT 
dimer and (d) a-MSH-ANT monomer constructs, the ligand-binding 
domain was located at the amino terminus and was followed by a 
short, flexible spacer region (three glycines and an amino-hexanoic 
acid (eAhx)), a longer, polylysine spacer, a cysteine residue (present in 
dimers only) and a 3-alanine residue. The (e) bombesin dimer and (f) 
bombesin monomer peptides were synthesized in the opposite 
direction with the ligand domain at the carboxyl terminus. 
the MSH peptides, the carboxyl terminus is crucial for 
bombesin binding. 
Following high-pressure liquid chromatography (HPLC) 
purification, both cysteine- and non-cysteine-containing 
peptides were oxidized by treatment with 20 % DMSO for 
4 h [ZZ]. Peptides were then repurified by size-exclusion 
HPLC (Fig. 2). 
Melanocyte dispersion assay 
We have developed a rapid, functional assay for G- 
protein-coupled receptors in frog-melanophore cells 
[ 16-201. Ligands that mediate increases in cellular cyclic 
AMP levels in these cells, such as or-MSH, or that 
stimulate phosphatidylinositol (PI) metabolism, such as 
endothelin 3 [19], cause pigment dispersion and cell 
darkening in these cells, whereas inhibitors of cyclic AMP 
synthesis like melatonin cause pigment aggregation and 
cell lightening. 
In this study we determined the effect of monomeric and 
dimeric peptides on pigment dispersion. In wild-type 
melanophores, the monomeric and dimeric o.-MSH 
peptides stimulated dispersion in a time- and dose- 
dependent manner (Fig. 3). The or-MSH dimer stimulated 
Research Paper Bivalent peptide ligands Carrithers and Lerner 539 
Fiaure 2 
(a) 3.5 r 
- 
E 
3.0 - 
= 2.5 - 
t 
gJ 2.0 - 
V 
$ 1.5- 
5 
e 
1.0- 
g 0.5 - 
9 o-- 
I I I I I 1 
25 30 
RetenTon tit4 (mi$ 
50 
I I I I I I I I 
20 25 30 35 40 45 50 55 
Retention time (mid 
Purification of peptides. Following oxidation in 20 % DMSO, monomer 
and dimer peptides were repurified by HPLC size-exclusion 
chromatography (Pharmacia Superose 6 column). Representative 
chromatograms are shown to demonstrate purification of (a) dimer and 
(b) monomer peptide. The dimer required two gel filtration purification 
steps. The retention times (RJ were -39.0 and -44.0 min for the 
dimer and the monomer, respectively. Molecular weights were 
confirmed by mass spectroscopy, and concentrations were determined 
by amino-acid analysis (data not shown). 
dispersion with an EC,, (at t = 30 min) that was diminished (Fig. 4b). The monomer did not stimulate 
approximately seven-fold lower than the monomer value dispersion below a concentration of 1 FM. Above 1 FM, 
(Fig. 3b). Calculated EC,, values were 51.8 + 5.4 nM and all peptides stimulated a small but significant degree of 
372 + 18 nM for the dimer and monomer, respectively. nonspecific pigment dispersion. 
The effects of a dimeric o-MSH-ANT on pigment To assess whether similar effects could be observed for 
dispersion were also examined. As expected, the other ligands, wild-type cells were transfected with a 
monomer inhibited o-MSH-mediated dispersion in a plasmid encoding the human bombesin receptor. This 
dose dependent manner with an IC,, of 120 + 6 nM receptor is linked functionally to PI hydrolysis and has 
(Fig. 4a). The dimer also inhibits a-MSH-mediated been demonstrated to mediate pigment dispersion 
dispersion (Fig. 4a) but with a two-fold lower IC,, following transfection [15]. Similar to the results obtained 
(57 ? 74 nM), although it was not possible to calculate with the o-MSH peptides, the bombesin dimer 
this value accurately because at higher concentrations stimulated pigment dispersion in a dose-dependent 
(~100 nM) the dimeric form predominantly stimulated manner with an EC,, approximately five-fold lower than 
dispersion (Fig. 4b). In the absence of a-MSH, the the corresponding monomer (Fig. 5). The EC,, was 
calculated EC,, for the dimer was 138 -C 4 nM; however, 23.4 + 5.6 nM for the dimer and 110 + 9 nM for the 
above a concentration of -350 nM, dimer agonism monomer. The bombesin peptides did not stimulate 
Figure 3 
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The stimulation of melanocyte dispersion by a-MSH dimer is 
dependent on both time and dose. (a) The dimer was added to a final 
concentration of 0 1 nM, 0 10 nM, 0 25 nM, A 50 nM, 0 100 nM or 
W 500nM. (b) Values for both the monomer (0) and dimer (0) are 
shown. Calculated EC,, (t = 30 min) values were 51.8 2 5.4 nM and 
372 2 18 nM for the monomer and dimer, respectively. Each point in 
the graph represents the mean from triplicate samples. 
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Monomeric a-MSH-ANT acts only as an antagonist, but at high 
concentrations the dimer is also an agonist. (a) Dispersion mediated by 
cx-MSH (5 nM) is inhibited by monomeric a-MSH-ANT (0; 
IC,, = 120 f 6 nM) and dimeric a-MSH-ANT (0; IC,, = 57 ? 74 nM) 
in a dose-dependent manner. (b) At higher concentrations, and in the 
absence of a-MSH, the dimeric a-MSH-ANT (0) acts as an agonist 
with an EC,, = 138 2 4 nM. No significant dispersion was observed in 
the presence of the monomer (0) alone. Each point in the graph 
represents the mean from triplicate samples. 
dispersion in wild-type (untransfected) melanophores 
within the concentration range used (data not shown). 
Discussion 
The present study demonstrated that dimeric peptides 
targeted to the a-MSH and bombesin receptors have an 
affinity approximately five to seven-fold higher than the 
corresponding monomers. As the dimers contain twice the 
number of potential ligands, the avidity effect was slightly 
more than two-fold. Although this effect is modest, it is 
the first demonstration to our knowledge that an entirely 
synthetic agonist peptide dimer can enhance G-protein- 
mediated signaling. 
Our results for the two agonist peptides rx-MSH and 
bombesin were similar to those previously reported for 
gonadotropin-releasing hormone (GnRH) peptides [14]. 
In that study, short, crosslinked GnRH peptide dimers 
Figure 5 
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Dimeric bombesin is a more potent agonist than the monomer. In 
melanophores transfected with a plasmid encoding the bombesin 
receptor, the bombesin monomer (0) and dimer (0) stimulated 
dispersion in a dose-dependent manner. The EC,, (t = 30 min) was 
23.4 2 5.6 nM for the dimer and 110 ? 9 nM for the monomer. Each 
point in the graph represents the mean from triplicate samples. 
were slightly less potent than native GnRH in a functional 
luteinizing hormone release assay, but generation of more 
widely spaced ligand sites by incubation of the dimers 
with anti-GnRH antibodies resulted in an increase in 
activity of approximately four-fold. 
It remains unclear why, in both our study and the prior 
one, the effect of bivalent binding to G-protein-coupled 
receptors is relatively modest. One possible explanation 
is that the l3r subunits of the G-protein complex may 
prevent excessive signal amplification. Furthermore, 
models that predict an affinity increase of an order of 
magnitude or more assume a very high concentration of 
antigen or receptor on the target surface [l]. In the case 
of G-protein-coupled receptors, the local concentration 
of receptor is probably a limiting factor in affinity 
enhancement by multivalency. 
It is also possible that the design of our dimer is suboptimal 
and that only a small percentage of ligands crosslink to two 
receptors simultaneously. The length of either the flexible 
spacer or the longer polylysine region may be too short or 
too long to obtain optimal binding, the distance between 
binding sites (>40 A) may be large enough to limit the 
entropic benefits of a chelate-like effect [1,4], or the 
polylysine backbone may have such a high background of 
non-specific binding that bivalent binding is a rare event. 
Future designs must attempt both to optimize the length of 
the spacer regions, and to decrease the total amount of 
charge without decreasing solubility significantly or 
eliminating the potential carrier function of polylysine. 
Perhaps the increased potency of the dimeric peptides is 
not due to a chelate-like effect, but rather to enhanced 
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signaling through G proteins. In the prior GnRH-receptor 
studies, Conn hypothesized that microaggregation of the 
receptor proteins may facilitate second messenger events 
[14,15]. More recent molecular studies of G-protein- 
coupled receptors suggested that these proteins can interact 
and form dimers that involve the exchange of amino- and 
carboxy-terminal domains [23]. These dimers may activate 
G proteins more efficiently than monomeric receptors. 
Further studies are needed to resolve these issues. 
Perhaps the most interesting and clinically useful 
observation in this study was that the dimeric (-w-MSH- 
ANT acted as an agonist. This result is also reminiscent of 
a prior finding by Conn and coworkers [15], who 
demonstrated that antibody-mediated dimerization of a 
GnRH antagonist could convert that ligand to an agonist. 
In our study, at low concentrations the (w-MSH-ANT 
dimer acted as an antagonist, but at higher concentrations 
it had agonist activity. We hypothesize that the dimers 
may mediate a cooperative effect when the two ‘arms’ of 
the ligand are bound to adjacent receptors. In this 
scenario, receptor microaggregation, as Conn et al. 
suggested, or dimerization can occur and is sufficient to 
stimulate a second messenger response [14,15]. The 
agonism of dimeric antagonists diminished at higher 
concentrations in both studies. This result suggests that 
the concentration of the receptor may become rate 
limiting at very high ligand concentrations [24], with 
monomeric binding of ligand saturating receptor-binding 
sites, and resulting in inhibition of receptor dimerization. 
present study was to design, synthesize and characterize 
monospecific peptide dimers that had the potential to 
bind to two adjacent G-protein-coupled receptors. Using 
a functional assay in frog melanophore cells, we 
demonstrated a modest increase in potency with dimeric 
agonists and conversion of antagonist peptides to 
agonists following ligand dimerization. The results with 
the dimeric antagonist suggests a potentially powerful 
way to target drugs to specific cell types. We propose that 
bispecific dimeric antagonists (each ligand ‘arm’ contains 
antagonists to two different receptors) would only act as 
agonists on cells expressing both receptor types, and 
therefore would only be endocytosed efficiently by those 
cells. These constructs could potentially increase delivery 
to specific cell populations by an order of magnitude. 
Materials and methods 
Peptide synthesis 
Peptide synthesis, analytical HPLC, laser-desorption mass spec- 
troscopy and amino-acid analysis were performed at the W.M. Keck 
Foundation Resource Laboratory of Yale University. Peptides were 
synthesized by solid phase on a Rainin Symphony multiple peptide 
synthesizer using Q-fluorenylmethyloxycarbonyl (Fmoc) chemistry. 
Following cleavage from the rink amide methylbenzhydrylamine 
(MBHA) resin by trifluoroacetic acid (TFA), peptides were analyzed 
by reverse phase HPLC (Vydec Cl 8 column) and mass spectroscopy. 
HPLC 
HPLC purification of peptides was performed on a Pharmacia SMART 
system using Superdex peptide and Superose-6 size-exclusion columns. 
Following synthesis, peptides were purified on a Superdex Peptide 
column in phosphate-buffered saline (PBS) at a flow rate of 50 ~1 min-’ 
and used immediately for oxidation reactions. Following oxidation, 
These results with antagonist dimers suggest a possible 
monomers and dimers were repurified on a Superose-6 column in PBS at 
mechanism for enhanced cell targeting by dimeric 
a flow rate of 50 ~1 min-‘. Dimers usually required two successive gel 
filtration steps to achieve suitable purity. Peptides were stored in PBS at 
bispecific antagonists [Z]. In the present study, we -20 “C. The concentration of the peptides was determined by amino-acid 
synthesized only monospecific dimers. In other words, the analysis, and molecular weights were confirmed by mass spectroscopy. 
ligand domains were the same in both ‘arms’ of the 
molecule. Using a similar synthesis strategy, it is possible 
to synthesize bispecific dimers. For example, one ligand 
region could contain an a-MSH-ANT while the other 
domain could consist of a bombesin antagonist. Hypo- 
thetically, bispecific dimeric antagonists would have 
agonist activity only against cells expressing both receptor 
types, and these target cells would specifically endocytose 
the dimer. Cells only expressing one or none of the 
receptors would endocytose the dimer far less efficiently. 
Combined with the benefits of enhanced avidity, 
bispecific dimeric antagonists potentially could enhance 
uptake by targeted cells by an order of magnitude. Future 
studies are needed to test this hypothesis as well as 
optimize the design and synthesis of these molecules. 
Significance 
The design of agents that can deliver low molecular 
weight drugs and DNA to specific cell types or across 
the blood brain barrier has become increasingly 
important in clinical pharmacology. The goal of the 
Oxidation 
After peptides were purified on a Superdex peptide column, they were 
oxidized at room temperature for 4 h in PBS (pH = 7.0) containing 20 o/, 
DMSO [15]. The average yield for the dimeric peptides was -20 o/o. 
Functional bioassay 
Xenopus laevis melanophores were maintained in culture as described 
previously [l l-l 31. Transient expression of human bombesin-receptor 
plasmid DNA (pJG3.6BR) in melanophores was achieved by 
electroporation [12]. Melanophores were plated (15 000 per well) in 
96-well tissue culture plates (Falcon), and time- and dose-response 
curves were obtained by microtiter-plate assays [lo-141. Prior to 
addition of monomeric or dimeric peptides, cells were washed and 
then incubated for 1 h with 0.7 x Leibovitz 15 medium supplemented 
with 1 nM melatonin. This preincubation causes the cells to aggregate 
their pigment and lighten. Drugs were added to the microtiter wells in 
20 ~1 aliquots at 10x their final concentration. For IC,, curves, the 
media was supplemented with 5 nM a-MSH. 
Phototransmission was measured at 620 nm using a 340 ATTC 
microtiter-plate reader (SLT Lab Instruments). Transmission readings 
were taken 1 h following the addition of melatonin (Ti), and drugs were 
added immediately. Additional readings (Td were made at various time 
points (5-60 min). Data was curve fitted by nonlinear regression with 
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y= 1 - (T,/T,). The final data were normalized and expressed as a 
percentage of maximal pigment dispersion (y,&. 
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